Which Hedge Funds Own CLYM — Climb Bio, Inc. Common Stock

12 of the hedge funds we track hold CLYM, worth $260.8M combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 5 opened a new position, 1 added, 5 trimmed, 4 exited.

9 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at CLYM · All tracked funds